Clinical observations and studies on different animal models of acquired epilepsy consistently demonstrate that blood-brain barrier (BBB) leakage can be an important risk factor for developing recurrent seizures. However, the involved signaling pathways remain largely unclear. Given the important role of thrombin and its major receptor in the brain, protease-activated receptor 1 (PAR1), in the pathophysiology of neurological injury, we hypothesized that PAR1 may contribute to status epilepticus (SE)-induced epileptogenesis and that its inhibition shortly after SE will have neuroprotective and antiepileptogenic effects. Adult rats subjected to lithium-pilocarpine SE were administrated with SCH79797 (a PAR1 selective antagonist) after SE termination. Thrombin and PAR1 levels and neuronal cell survival were evaluated 48 h following SE. The effect of PAR1 inhibition on animal survival, interictal spikes (IIS) and electrographic seizures during the first two weeks after SE and behavioral seizures during the chronic period was evaluated. SE resulted in a high mortality rate and incidence of IIS and seizures in the surviving animals. There was a marked increase in thrombin, decrease in PAR1 immunoreactivity and hippocampal cell loss in the SE-treated rats. Inhibition of PAR1 following SE resulted in a decrease in mortality and morbidity, increase in neuronal cell survival in the hippocampus and suppression of IIS, electrographic and behavioral seizures following SE. These data suggest that the PAR1 signaling pathway contributes to epileptogenesis following SE. Because breakdown of the BBB occurs frequently in brain injuries, PAR1 inhibition may have beneficial effects in a variety of acquired injuries leading to epilepsy.
Introduction
Impairment of blood-brain barrier (BBB) integrity is commonly observed in conjunction with traumatic brain injury, stroke, tumors and infections; conditions which can lead to seizures and the development of epilepsy (Albayrak et al., 1997; Chodobski et al., 2011; Latour et al., 2004; On et al., 2013; Stolp and Dziegielewska, 2009; Vezzani and Friedman, 2011) . Short-and long-lasting increases of BBB permeability during seizures and status epilepticus (SE) have been demonstrated in different animal models of chronic epilepsy (Friedman, 2011) and in patients with epilepsy (Mihály and Bozóky, 1984; Oby and Janigro, 2006) . Moreover, BBB opening or intracerebral injection of blood components may directly evoke seizures and lead to the generation of an epileptic focus (Lee et al., 1997; van Vliet et al., 2007) . However, the specific pathways activated as a consequence of BBB disruption participating in the development of chronic epilepsy remain unclear.
There is now substantial evidence that besides its key role in coagulation, serum-derived protein thrombin participates in many mechanisms important for normal brain functioning and during pathological conditions involving abnormal neuronal synchronization, neurodegeneration and inflammation (Luo et al., 2007; Turgeon et al., 2000) . Among the possible blood components involved in seizure generation during BBB opening (albumin, iron, thrombin) only thrombin has been shown to produce early-onset seizures (Lee et al., 1997; Tomkins et al., 2007; Willmore et al., 1978) . Depending on the concentration, the effect of thrombin in the CNS might be protective or deleterious (Xi et al., 2003) . At low concentrations, thrombin rescues neurons from death after brain insults (Jiang et al., 2002) . In contrast, the alteration of BBB integrity during pathological conditions may lead to dramatic increases of thrombin levels in the CNS (Woitzik et al., 2011) . Thrombin, through the activation of specific protease-activated receptors (PAR) expressed by neurons and glial cells, is implicated in the exacerbation of brain damage, seizures and induction of Neurobiology of Disease 78 (2015) 68-76 
